Publications (International):

• Ramezani A, Aghasadeghi MR, Ahmadi F, Razeghi E, Eslamifar A, Banifazl

M, Sofian M, Bahramali G, Hekmat S and Aghakhani A. Reduction of

Isolated Anti-HBc and Occult HBV Infection in Dialysis Patients. Nephro-

Urology Monthly (in press)

• Ramezani A, Kalantar E, Aghakhani A, Banifazl M, Foroughi M, Hosseini S,

Eslamifar A, Esmaeilzadeh A, Sadrpour P and Mohraz M. Lack of Association

between Interleukin-10 Gene Promoter Polymorphisms with HIV

Susceptibility and Progression to AIDS. Iranian Journal of Pathology 10 (2),

141 -148 (2015)

• Eslamifar A, Ramezani A, Azadmanesh A, Bidari-Zerehpoosh F, Banifazl M

and Aghakhani A. Assessment of the Association between Human

Papillomavirus Infection and Breast Carcinoma. Iranian Journal of Pathology

10(1):41-46(2015)

• Aghakhani A, Hamkar R, Ramezani A, Bidari-Zerehpoosh F, Sabeti S,

Ghavami N, Banifazl M, Rashidi N, Eslamifar A. Lack of Human

Papillomavirus DNA in Colon Adenocarcinama and Adenoma. Journal of

Cancer Research and Therapeutics 10(3):531-534(2014)

• Eslamifar A, Ramezani A, Banifazl M, Sofian M , Mahdaviani F, Yaghmaie F,

Aghakhani A. Immunity to diphtheria and tetanus among blood donors in

Arak, central province of Iran. Iranian Journal of Microbiology 6(3):190-193

(2014)

• Sofian M, Velayati AA, Aghakhani A, McFarland W, Farazi AA, Banifazl M,

Eslamifar A, Ramezani A. Comparison of two durations of triple drug therapy

in patients with uncomplicated brucellosis: a randomized controlled trial.

Scandinavian Journal of Infectious Diseases 46(8):573-577 (2014)

• Ramezani A, Amirmoezi R, Volk JE, Aghakhani A, Zarinfar N, McFarland

W, Banifazl M, Mostafavi E, Eslamifar A and Sofian M. HCV, HBV, and

HIV seroprevalence, co-infections, and related behaviors among male

injection drug users in Arak, Iran. AIDS Care 26(9): 1122–1126 (2014)

• Ramezani A, Janbakhsh A, Gol-Mohammadi M, Banifazl M, Aghakhani A,

Eslamifar A, Pournasiri Z, ….. Serological Response to One Intradermal or

Intramuscular HBV Vaccine Booster Dose in HIV Infected Nonresponders to

Standard Vaccination. Perspective in Clinical Research 5 (3):134-8(2014)

• Sofian M, …., Banifazl M, Aghakhani A, Eslamifar A, ……and Ramezani A.

Hematological Reference Values for Healthy Males in the Central Part of Iran.

Iranian Journal of Pathology 9(1):50-55 (2014)

• Sofian M, Aghakhani A, Banifazl M, Eslamifar A, Zolfaghari F, Sarmadian H,

Ramezani A. Differentiation of Brucella-Induced Epididymo-orchitis from

Nonspecific Epididymo-orchitis in an Endemic Area for Brucellosis. J Med

Microbiol Infec Dis.1 (1): 8-13 (2013)

• Ramezani A, Eslamifar A, Banifazl M and Aghakhani A. Importance of

Isolated Anti-HBc in Detection of Occult Hepatitis B Virus Infection in

Hemodialysis Patients. Therapeutic Apheresis and Dialysis 17(6):644 (2013)

• Sofian M, Safaeipour L, Aghakhani A, Sharif MR, Banifazl M, ….. Eslamifar

A, … Ramezani A. Screening of Family Members of Patients with Acute

Brucellosis in an Endemic Area. Iranian Journal of Microbiology 5(3):215-

219(2013)

• Ramezani A, …….., Eslamifar A , Mohraz M, Banifazl M, Bidari-Zerehpoosh

F, Yaghmaei F, McFarland W, …….., Mostafavi E and Aghakhani A.

Hepatitis E Virus Infection in Patients Infected with HIV in an Endemic Area

in Iran. International Journal of STD & AIDS 24(10) 769–774 (2013)

• Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi SH,

Aghakhani A, Mashayekhi P. Seroprevalence of Hepatitis E Virus infection

among Volunteer Blood Donors in Central Province of Iran in 2012. Iranian

Journal of Microbiology 5(2):172-176(2013)

• Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl M, ….,

Eslamifar A, Sadat M, Ramezani A . Frequency and Genotype of Hepatitis D

Virus Infection in Patients Infected with HIV and Hemodialysis Patients.

Hepatitis Monthly 13(5): e7481(2013)

• Sofian M, Kalantar E, Aghakhani A, Hosseini S, Banifazl M, ….., Eslamifar A

and Ramezani A. No Correlation between Interleukin-10 Gene Promoter

Polymorphisms and Hepatitis B Virus Infection Outcome. Hepatitis Monthly

13(5): e8803 (2013)

• Ramezani A, Banifazl M, Eslamifar A , Ahmadi F, Razeghi E and Aghakhani

A. Outcome of Hemodialysis Patients with Occult Hepatitis B Virus Infection

At 4 Year Follow-up. Journal of Gastrointestinal and Liver Diseases 22(1):12-

15(2013)

• Sofian M, Sheikholeslami M, Mahdaviani F, Aghakhani A, Banifaz M,

Eslamifar A, Sarmadian H, Deiri G, Ramezani A. Low Prevalence of Brucella

agglutinins in Blood Donors in Central Province of Iran. Iranian Journal of

Microbiology 5(1):24-27(2013)

• Sofian M, Aghakhani A, FaraziA, Banifazl M, Eslamifar A, Rashidi N,

Khadem-Sadegh A and Ramezani A. Serum Profile of T helper 1 and T helper

2 Cytokines in Hepatitis C virus Infected Patients. Hepatitis Monthly

12(12):e6156 (2012)

• Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi A, McFarland W,

Eslamifar A and Ramezani A. Viral hepatitis and HIV infection among

injection drug users in a central Iranian city. Journal of Addiction Medicine

6(4):292-6 (2012)

• Aghakhani A, Banifazl M, Eslamifar A, Ahmadi F and Ramezani A. Viral

Hepatitis and HIV Infection in Hemodialysis Patients. Hepatitis Monthly

12(7): 463-464(2012)

• Ramezani A, Banifazl M, Eslamifar A, Sofian M and Aghakhani A. Occult

hepatitis B infection in different high risk patients. Hepatitis Monthly 12(7):

467-468(2012)

• Aghakhani A, Banifazl M, Velayati AA, Eslamifar A and Ramezani A. Occult

Hepatitis B Virus Infection in Hemodialysis Patients: A Concept for

Consideration. Therapeutic Apheresis and Dialysis 16(4):328-33(2012)

• Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A and Aghakhani

A. The Influence of Human Leukocyte Antigen and IL-10 Gene

Polymorphisms in Hepatitis B Virus Outcome. Hepatitis Monthly 12(5):320-

325(2012)

• Eslamifar A, Ramezani A, Banifazl M, Khadem-Sadegh A and Aghakhani A.

Seroprevalence of IgG Antibodies against Bordetella Pertussis in Different

Age Groups in Tehran. Iranian Journal of Pathology 7(3):171-176(2012)

• Soufian S , Aghakhani A, Mohraz M, Banifazl M, Eslamifar A, Boland-

Ghamat Z, Khadem-Sadegh A and Ramezani A. No evidence of the Th1 to

Th2 cytokine shift during the course of HIV infection. Iranian Journal of

Pathology 7(2):88-93(2012)

• Eslamifar A, Ramezani A, Banifazl M and Aghakhani A. Tetanus and

diphtheria seroprevalence in patients infected with human immunodeficiency

virus. Iranian Journal of Pathology 7(1):27-31(2012)

• Ramezani A, Banifazl M, Mohraz M, Eslamifar A, Rasoolinejad M and

Aghakhani A. Occult Hepatitis B Virus Infection: A Major Concern in HIV-

Infected Patients. Hepatitis Monthly 11(1):7-10 (2011)

• Aghakhani A, Banifazl M, Izadi N, McFarland W, Sofian M, Khadem-Sadegh

A,….Eslamifar A, Ramezani A. Persistence of antibody to hepatitis B surface

antigen among vaccinated children in a low HBV endemic area. World Journal

of Pediatrics 7(4):358-60 (2011)

• Aghakhani A, Hamkar R, Parvin M, …., Banifazl M, Eslamifar A, Izadi N,

Jam S and Ramezani A. The Role of Human Papillomavirus Infection in

Prostate Carcinoma. Scandinavian Journal of Infectious Diseases 43(1): 64-

69(2011)

• Ramezani A, Banifazl M, Eslamifar A and Aghakhani A. Association between

Human Papillomavirus Infection and Risk of Prostate Cancer (Review article).

Iranian Journal of Pathology 6 (1): 3-7(2011)

• Hamkar R, Mohraz M, Lorestani S, Aghakhani A, Truong HM, McFarland W,

Banifazl M, Eslamifar A, ……. and Ramezani A. Assessing Subtype and

Drug-Resistance Associated Mutations among Antiretroviral-Treated HIV

Infected Patients. AIDS 24 (suppl 2):S85–S91 (2010)

• Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Khadem-Sadegh A and

Ramezani A. Occult Hepatitis B Virus Infection in Hemodialysis Patients with

Isolated Hepatitis B Core Antibody: A Multicentre Study. Therapeutic

Apheresis and Dialysis 14(3):349–353 (2010)

• Ramezani A, Banifazl M, EslamifarA and Aghakhani A. Serological pattern of

anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals

in Iran. Journal of Infection in Developing Countries 4(10):658-661 (2010)

• Sofian M, Aghakhani A, Farazi AA, Banifazl M, …, Eslamifar A, Khadem-

Sadegh A, Izadi N and Ramezani A. Seroepidemiology of Hepatitis A Virus in

Children of Different Age Groups in Tehran, Iran: Implications for Health

Policy. Travel Medicine and Infectious Disease 8(3): 176-179 (2010)

• Sofian M, Aghakhani A, Banifazl M, …Eslamifar A,…Ramezani A. Lack

of occult hepatitis B virus infection among blood donors with isolated anti-

HBc living in a HBV low prevalence region in Iran. International Journal

of Infectious Diseases 14(4):e308–e310 (2010)

• Hamkar R, Aghakhani A, Soufian S, Banifazl M, ….., Eslamifar A and

Ramezani A. Surface Gene Mutations of Hepatitis B Virus among High

Risk Patients with Occult HBV Infection. Diagnostic Microbiology and

Infectious Disease 66(3):285-291(2010)

• Aghakhani A, Hamkar R, Zamani N, Eslamifar A, Banifazl M,

….Ramezani A. Hepatitis B Virus Genotype in Iranian Patients with

Hepatocellular Carcinoma . International Journal of Infectious Diseas13

(6):685-89(2009).

• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A,

Khadem-Sadegh A, Velayati AA. Frequency of Isolated Hepatitis B Core

Antibody in HIV-HCV Coinfected Individuals. International Journal of

STD & AIDS 20(5):336-338(2009)

• Ramezani A, Aghakhani A, Kalantar E, Eslamifar A, Banifazl M and

Velayati AA. HLA-A*3303 and *3301 Predispose Patients to Persistent

Hepatitis B Infection. Journal of Gastrointestinal and Liver Diseases

18(1):117-8(2009)

• Kariminia A, sharifnia Z, Aghakhani A, Banifazl M, Eslamifar A, Hazrati

M and Ramezani A. Comparison of QuantiFERON TB-G test to TST for

detecting latent tuberculosis infection in a high-incidence area containing

BCG-vaccinated population. Journal of Evaluation in Clinical

Practice15:148–151(2009)

• Ramezani A, Eslamifar A, ……and Aghakhani A. Efficacy and Long-term

Immunogenicity of Hepatitis B Vaccine in Hemodialysis Patients.

International Journal of Clinical Practice 63(3): 394-97(2009)

• Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A,….Taeb J,

Aghakhani A… Association of Human Leukocyte Antigen polymorphism

with Outcomes to Hepatitis B Virus Infection. Journal of Gastroenterology

and Hepatology 23(11):1716-1721 (2008).

• Ramezani A, Mohraz M, Vahabpour R,….Eslamifar A,….Aghakhani

A,…Hekmat S. Frequency of Hepatitis G Virus Infection among HIV

Positive Subjects with Parenteral and Sexual Exposure. Journal of

Gastrointestinal and Liver Diseases 17(3):269-72 (2008)

• Azadmanesh K, Mohraz M, Aghakhani A,……..Eslamifar A,….Ramezani

A. Occult Hepatitis B Virus Infection in HIV-Infected Patients with

Isolated Hepatitis B Core Antibody. Intervirology 51(4):270-274 (2008)

• Hekmat S, Mohraz M, Vahabpour R, Jam S, Bahramali G, Banifazl M,

Aghakhani A, Eslamifar A, Mahboudi F, Edalat R, Ramezani A.

Frequency and Genotype of GB Virus C among Iranian Patients Infected

with HIV. Journal of Medical Virology 80(11):1941-1946(2008)

• Ramezani A, Mohraz M, Banifazl M,….Eslamifar A,….and Aghakhani A.

Frequency and Associated Factors of Proteinuria in Iranian HIV-Positive

Patients. International Journal of Infectious Diseases 12(5):490-494(2008)

• Ramezani A, Eslamifar A,, ……and Aghakhani A. Persistence of Hepatitis

B Vaccine Immunity in Hemodialysis Patients .Therapeutic Apheresis and

Dialysis.12(2):143-146 (2008).

• Sofian M., Aghakhani A., Velayati A.A., Banifazl M, Eslamifar A. and

Ramezani A. Risk factors for human brucellosis in Iran: a case control

study. International Journal of Infectious Diseases 12(2):157-61(2008)

• Ramezani A. Gachkar L, Eslamifar A,….Detection of hepatitis G virus

envelope protein E2 antibody in blood donors. International Journal of

Infectious Diseases. 12(1):57-61(2008)

• Eslamifar A, Hamkar R, Ramezani A, ……and Aghakhani A. Hepatitis G

virus (HGV) Exposure in Dialysis Staff. Therapeutic Apheresis and

Dialysis. 11(5):370-374(2007)

• Norouzian D, Akbarzadeh A, …..and Eslamifar A. Stabilization of

Tyrosinase-Bovine serum albumin crystals by Glutaraldehyde. American

journal of Biochemistry and Biotechnology. 3(3):110-113(2007).

• Eslamifar Ali, Aghakhani A, Hamkar R, Ramezani A, et al..... Frequency

of Human Papillomavirus Infection in Iranian Esophageal Squamous Cell

Carcinoma patients. Scandinavian Journal of Infectious Disease .39(1):58-

62(2007)

• Eslamifar A, Hamkar R, Ramezani A, ……and Aghakhani A. Hepatitis G

Virus Exposure in Dialysis Patients. International Urology and

Nephrology .39(4): 1257-1263 (2007).

• Razzaghi-abyaneh M, Shams-Ghahfarokhi M, Eslamifar A. Inhibitory

effects of Akacid on growth and aflatoxin production by Aspergillus

parasiticus. Mycopathologia, Vol. 161: 245-249. (2006)

• Razzaghi-Abyaneh M, Shams-Ghahfarokhi M, Eslamifar A.

Ultrastructural evidences of growth inhibitory effects of a novel biocide,

Akasid. Toxicon, 48: 1075-1082. (2006)

• Sayah M, Beheshti S, Shokrgozar M.A, Eslamifar A, Deljoo Z. Anti

epileptogenic and anticonvulsant activity of interleukin 1β in amygdala-

kindled rats experimental neurology(2004)

Journal papers (Persian)

• Ramezani A, Eslamifar A, Banifazl M, Keyvani H, Razeghi E, Ahmadi F,

Amini M,Gachkar L, Bavand A, Aghakhani A. Occult HCV infection in

hemodialysis patients with elevated liver enzymes. Arak Medical

University Journal.16 (80): 34- 40 (2014)

• Eslamifar A, Aghakhani A, Mohraz M, Banifazl M, Foroughi M, Ansari F,

Bolandghamat Z, Ramezani A. Seroepidemiology of Hepatitis E Virus

Infection in HIV Infected Patients. Iranian Journal of Infectious Diseases

and Tropical Medicine 17(59):33-36(2013)

• Soufian S, Mohraz M, Aghakhani A, Banifazl M, Froughi M, Eslamifar A,

Boland-Ghamat Z, Khadem-Sadegh A and Ramezani A. TH1/TH2

Cytokine Levels in Human Immunodeficiency Virus Type 1 Infected

Patient. Iranian Journal of Infectious Diseases and Tropical Medicine

16(55):19-22(2012)

• Kalantar E, Ramezani A, Hosseini S, Aghakhani A, Zarin Far N, Banifazl

M ,………Eslamifar A and Sofian M. Interleukin-10 gene promoter

polymorphisms and hepatitis B virus infection outcome. Iranian Journal of

Infectious Diseases and Tropical Medicine 16(54):7-12(2011)

• Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl

M…… Eslamifar A and Ramezani A. Frequency of hepatitis D virus

infection in HIV positive and hemodialysis patients. Iranian Journal of

Infectious Diseases and Tropical Medicine 16(54):41-46(2011)

• Ramezani A, Hamkar R, Aghakhani A, Lorestani SH, Banifazl M, Truong

HH, McFarland W, Foroughi M, Eslamifar A and Mohraz M. Subtype

Mutations and Related Drug-Resistance in Anti-Retroviral Treated HIV

Infected Patients. Iranian Journal of Infectious Diseases and Tropical

Medicine15(50):1-7(2010)

• Izadi N, Aghakhani A, Banifazl M , … Eslamifar A , .., Khadem-Sadegh A

and Ramezani A. Persistence of Anti-HBs antibody in HB Vaccinated

Children in a Low Endemic Area for HBV. Iranian Journal of Infectious

Diseases and Tropical Medicine 14(47):39-42(2010)

• Eslamifar A, Aghakhani A, Banifazl M, Gachkar L, Khadem-Sadegh A,

Ramezani A. Seroprevalence of Bordetella Pertussis Antibodies in

Different Age Groups. Iranian Journal of Infectious Diseases and Tropical

Medicine 15(49):43-47(2010)

• Hamkar R, Parvin M, Ghavami N, Ramezani A, …, Banifazl M, ….,

Eslamifar A and Aghakhani A. Involvement of Human Papillomavirus

Infection in Prostate Carcinoma. Iranian Journal of Infectious Diseases and

Tropical Medicine 15(48):13-17(2010)

• Ramezani A, Azadmanesh K, Aghakhani A, Banifazl M, …. and Sofian

M. Frequency of occult hepatitis B virus infection in injection drug users.

Iranian Journal of Infectious Diseases and Tropical Medicine 15(48):39-

42(2010)

• Ramezani A, Hamkar R, Soufian S, Banifazl M ,……, Eslamifar A and

Aghakhani A. Genetic variability of the S gene of hepatitis B virus among

High Risk Patients with Occult HBV Infection. Iranian Journal of

Infectious Diseases and Tropical Medicine 14(47):13-18(2010)

• Velayati AA, Aghakhani A,....Eslamifar A....Ramezani A. Association of

polymorphism of HLA-DRB1*13 and HLA-A*33 alleles with outcome of

hepatitis B virus infection. Iranian Journal of Infectious Diseases and

Tropical Medicine 14(46): 11-14 (2009)

• Ramezani A, Sofian M, Banifazl M, …., Eslamifar A, Gachkar L,

Khadem-Sadegh A and Aghakhani A. Seroepidemiology of Hepatitis A

Virus in Children Residing in Tehran. Iranian Journal of Infectious

Diseases and Tropical Medicine 14(46):23-26 (2009)

• Ramezani A, Banifazl M, Eslamifar A, Gachkar L, Aghakhani A.

Prevalence of hepatitis G virus in the sera of HIV infected patients with

parenteral and sexual exposure. Iranian Journal of Infectious Diseases and

Tropical Medicine 14(45):27-29(2009)

• Ramezani A, Aghakhani A,…….. Eslamifar A, Sofian M. Occult hepatitis

B virus infection among blood donors in Arak. Iranian Journal of

Infectious Diseases and Tropical Medicine 14(45):37-40(2009)

• Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, Mohraz M.

Frequency of isolated anti-HBc in HIV- HCV co-infected patients. Iranian

Journal of Infectious Diseases and Tropical Medicine 14(45):17-22(2009)

• Ramezani A, Banifazl M,……Eslamifar A…..and Aghakhani A. Occult

hepatitis B virus infection in hemodialysis patients. Iranian Journal of

Infectious Diseases and Tropical Medicine14(44):27-30

• Ramezani A, Mohraz M, Banifazl M, Eslamifar A and Aghakhani A.

Significance of Hepatitis B Core Antibody as the Only Marker of Hepatitis

B Virus Infection. Iranian Journal of Pathology 4(2):80-84(2009)

• Ramezani A, Aghakhani A, Kalantar E, Banifazl M, Eslamifar A ,Velayati

AA. Association between Hepatitis B Virus Infection Outcome and HLA-

A and DRB1 Genotyping in North Part of Iran. Iranian Journal of

Pathology 4(2):71-74(2009)

• Ramezani A, Mohraz M,….,Aghakhani A, Eslamifar A…..Prevalence of

dyslipidemia and metabolic abnormalities in HIV-infected patients. Acta

Medica Iranica 47(2):83-88(2009)

• Ramezani A, ………Aghakhani A, Eslamifar A,…and Mohraz M.

Frequency of Occult Hepatitis B Virus Infection in HIV Infected Patients.

Iranian Journal of Infectious Diseases and Tropical Medicine13(43):17-

20(2009)

• Aghakhani A, Mohraz M, Banifazl M, …. Eslamifar A,…and Ramezani

A. Asymptomatic proteinuria in HIV-infected outpatients. Iranian Journal

of Infectious Diseases and Tropical Medicine 13(42):9-13(2008)

• Ramezani A, Eslamifar A,…… Aghakhani A ,…. High Blood Mercury

Levels in Iranian Infants: cause for concern. Iranian Journal of Pathology

3(4):186-190 (2008)

• Zahmatkesh M, Khadkhodaie M, …..Eslamifar A, Taeb J,…Proteinuria is

reduced by inhibition of inducible nitric oxide synthase in rat renal

ischemia/perfusion injury. Urmia Medical Journal.19(2):34-41(2008)

• Eslamifar A, Razzaghi-Abyaneh M,…… Ramezani A, Deljoodokht Z and

Aghakhani A. Frequency and Identification of Fungal Strains in Chronic

Rhinosinusitis Patients. Iranian Journal of Pathology 3(3):135-139(2008)

• Ramezani A, Aghakhani A ,… Eslamifar A,….Anemia prevalence and

related factors in a cohort of HIV- infected patients .Iranian Journal of

Pathology 3(3):125-128(2008)

• Hamkar R, Zamani N, Ramezani A, Eslamifar A, ......and Aghakhani A.

Identification of Hepatitis B Virus Genotype in Iranian Hepatocellular

Carcinoma Patients. Iranian Journal of Infectious Diseases and Tropical

Medicine13(41):23-29(2008)

• Ramezani A,…… Aghakhani A, Eslamifar A,….. Prevalence and

Genotype of Hepatitis G virus infection in HIV Positive Patients. Iranian

Journal of Infectious Diseases and Tropical Medicine13(41):7-13(2008)

• Ramezani A, Aghakhani A, Eslamifar A….Taeb J,….. Long-Term

Immunity of Hepatitis B Vaccine in Patients Undergoing Hemodialysis.

Iranian Journal of Infectious Diseases and Tropical Medicine.13(40):21-

24(2008)

• Kariminia A, sharifnia Z, Aghakhani A, .. Eslamifar A,… and Ramezani

A. Evaluation of the blood gamma interferon assay for detection of latent

Tuberculosis infection: potential to replace the Mantoux skin test. Iranian

Journal of Infectious Diseases and Tropical Medicine13 (40):1-4(2008).

• Eslamifar A, Ramezani A, Razzaghi Abyaneh M, Fallahian V,

Mashayekhi P, Hazrati M, Askari T, Fayaz A and Aghakhani A. Animal

Bites in Tehran, Iran. Archives of Iranian Medicine 11(2):200-202(2008)

• Ramezani A, Mohraz M, Banifazl M,….Eslamifar A,….and Aghakhani A.

Metabolic abnormalities in HIV-positive patients receiving highly active

antiretroviral therapy. Iranian Journal of Pathology2 (4):154-58 (2007).

• Jam S, Sabzevari D, Aghakhani A, Eslamifar A, Banifazl M and Ramezani

A. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas

aeruginosa in a pediatric hospital. Iranian Journal of Pathology 2(4):144-

48(2007)

• Soofian M,…. Eslamifar A, Aghakhani A, Ramezani A. Eosinophilic

gastroenteritis: A case report. Iranian Journal of Infectious Disease and

Tropical Medicine .12(38):63-6(2007).

• Ramezani A, Eslamifar A, Aghakhani A,…..Blood mercury levels in

infants receiving vaccines containing Thimerosal. Iranian Journal of

Infectious Disease and Tropical Medicine. 12(38):17-20(2007).

• Eslamifar A, Tirgari F, Hamkar R, Ramezani A …… Deljoodokht Z and

Aghakhani A. Role of the Human Papillomavirus infection in Esophageal

Squamous Cell Carcinoma. Iranian Journal of Pathology. 2(1):11-

16(2007).

• Naraghi M, Amidi Y, Eslamifar A. Demonstration of microbial biofilm in

Ethmoidal sinus of refractory chronic rhinosinusitis patients by SEM. The

Iranian journal of Otorhinolaryngology 18(46):181-4(2007).

• Ramezani A, Gachkar L, Eslamifar A…Prevalence of Hepatitis G virus

exposure in blood donors. Infectious diseases and tropical medicine

journal. 37(12).( 2007).

• Mahmoodi SMM, Hamkar R, …Eslamifar A…Determination of Human

Papillomavirus genotypes in cervical cancer speciemens in Yazd province.

Infectious diseases and tropical medicine journal. 37(12)( 2007).

• Ramezani A, Aghakhani A……Eslamifar A…. Natural YMDD mutants in

chronic B hepatitis. Iranian Journal of Infectious Diseases and Tropical

Medicine. 12(37): 1-6(2007).

• Eslamifar Ali, Aghakhani A, Hamkar R, Ramezani A,..... Frequency of

Human Papillomavirus Infection in Iranian Esophageal Squamous Cell

Carcinoma patients. Scandinavian Journal of Infectious Disease .39(1):58-

62(2007).

• Eslamifar A., Aghakhani A. Ramezani A.,... Detection of Hepatitis G

Virus Envelope Protein E2 Antibody in Dialysis Staff .Iranian Journal of

Infectious Diseases and Tropical Medicine. 11(35): 73-79 (2007).

• Eslamifar A., Aghakhani A. , Hamkar R., Ramezani A., Tirgari F., Frootan

H., Mirmomen Sh., Gheini MH. , Deljoodookht Z., Taeb J. Detection of

High Risk Human Papillomaviruses in Esophageal Squamous Cell

Carcinoma by PCR and DNA Sequencing. Iranian Journal of Infectious

Disease and Tropical Medicine. 11(33): 1-5(2006).

• Shahabi P, Mirnajafi J, Eslamifar A, Deljoo Z. Influence of electrical

destruction of Amygdal on convulsion due to..... Physiology and

Pharmacology Journal, Vol. 9, No. 2. (2005)

• Ramezani A, Mohraz M, Feizabadi M, Asgharzadeh A, Parastan R,

Eslamifar A, Aliahmadi A, Velayati A.A Molecular epidemiology of

clinical strains of enteococci Faecium in Tehran hospitals. Infectious

Diseases and Tropical Medicine Journal, Vol. 10, No. 31. .(2005)

• Ramezani A, Eslamifar A, Hazrati M. Study vaccine includes thiomersal

and relations with neurodevelopment disorders in neonates and embryonic

periods. Iranian Journal of Infectious Disease and Tropical Medicine, Vol.

9, No. 26. (2004)

• Ramezani A, Eslamifar A, Eslami N, Nazgooie F. Epidemiology of animal

rabies in Tehran province. Iranian Journal of Infectious Disease and

Tropical Medicine, Vol. 9, No. 25. (2004)

• Ramezani A, Eslamifar A, Nazgooie F, Falahian L, Hazrati M, Naseri

M.R. (2004) Study Epidemiology of animal bites in persons referred to

Institute Pasteur of Iran (Tehran province). Iranian Journal of Infectious

Disease and Tropical Medicine. Vol. 9, No. 27.( 2003)

• Ramezani A, Mohraz M, Asadi S, Nazgooie F, Eslamifar A. Survey

situation of nosocomial infection due to enterococci in Tehran hospitals.

Infectious Diseases and Tropical Medicine Journal, Vol. 7, No. 19. (2002)

Books:

• New edition of "Guide to antimicrobial therapy and vaccination" .Chief

Editor: Iranian Society for Infectious Diseases and Tropical Medicine

publication (2013)

• New edition of "Guide to antimicrobial therapy and vaccination". Pousheh

Publication, Tehran, Iran (2012)

• New edition of "Guide to antimicrobial therapy" .Chief Editor: Iranian

society for infectious diseases and tropical medicine publication

( 2005,2006,2007,2008,2009,2010)

• Application of Nanotechnology in medicine, Sharh Publication, Tehran

(2005).

• Health for Everybody. ISBN: 964-5888-81-6. Ahrar Publication in Tabriz

(2005)